# Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult Subjects

> **NCT01366326** · PHASE1 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **DRUG:** Methylnaltrexone bromide

## Key facts

- **NCT ID:** NCT01366326
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01366326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01366326, "Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01366326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*